Mouse zygote development in culture medium without protein in the presence of ethylenediaminetetraacetic acid.
Development of zygotes from a hybrid-inbred (B6D2F1) and two random-bred (CD1 and CF1) strains of mice were compared after culture in several modifications of a simple, chemically defined medium based on Earle's Balanced Salts Solution. When cultured without the addition of protein or the chelating agent, ethylenediaminetetraacetic acid (EDTA), none of the zygotes reached the blastocyst stage. The addition of EDTA or protein significantly improved embryo development to blastocysts (p less than 0.05). The degree of improvement was dependent upon the strain of the female (85% or 91% for B6D2F1, 56% or 45% for CD1, and 19% or 28% for CF1, respectively). The addition of protein to the media in the presence of EDTA did not further improve embryo development. In all supportive conditions, zygotes from B6D2F1 females developed to blastocysts better than those from CD1 or CF1 females; embryos of the latter strain exhibited the lowest rates of development in vitro. Glycine and alanine (20 microM) partially substituted for EDTA; the decreased hybrid-inbred embryo development to blastocysts (20% and 26%, respectively) obtained in the presence of the amino acids suggested, however, that the stimulatory effect of EDTA on embryo development was other than as a source of fixed nitrogen. The rates of development observed with an alternate chelating agent, citric acid (less than or equal to 20% vs. 83% blastocysts, p less than 0.01), although better than the unsupplemented medium, were significantly less effective than EDTA-supplemented medium (83% blastocysts, p less than 0.01). The results of this study suggest that the protective effect of proteins in culture medium may be more important than their nutritive role.(ABSTRACT TRUNCATED AT 250 WORDS)
Fissore
R A
RA
Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, Massachusetts 02115.
Jackson
K V
KV
Kiessling
A A
AA
D000818:Animals; D001151:Arsenic / Q000032:analysis; D002104:Cadmium / Q000032:analysis; D002614:Chelating Agents / Q000494:pharmacology; D003470:Culture Media / Q000032:analysis / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004492:Edetic Acid / Q000032:analysis / Q000494:pharmacology*; D005314:Embryonic and Fetal Development / Q000187:drug effects* / Q000502:physiology; D005260:Female; D007854:Lead / Q000032:analysis; D008297:Male; D008628:Mercury / Q000032:analysis; D051379:Mice; D008815:Mice, Inbred Strains; D011506:Proteins / Q000032:analysis / Q000494:pharmacology* / Q000502:physiology; D012643:Selenium / Q000032:analysis; D012710:Serum Albumin, Bovine / Q000032:analysis / Q000494:pharmacology; D015053:Zygote / Q000187:drug effects* / Q000502:physiology
D002614:Chelating Agents; D003470:Culture Media; D011506:Proteins; D002104:Cadmium; D012710:Serum Albumin, Bovine; D007854:Lead; D004492:Edetic Acid; D008628:Mercury; D012643:Selenium; D001151:Arsenic